Domain 1: Notable findings from the 5IQ Comparative analysis of osteoporosis clinical guidelines from across the Asia Pacific region This domain of the questionnaire includes a series of open-ended questions which invite you to share your opinions on the most notable findings of the 5IQ analysis report. | ||
---|---|---|
5IQ item | Question | Options |
Identification | Considering the groups of individuals that the various guidelines recommend should be identified for bone health assessment, what are the most notable findings in the analysis? (You can indicate more than one) | [Free text] |
Investigation | Considering the investigations that the various guidelines recommend should be undertaken, what are the most notable findings in the analysis? | [Free text] |
Information | Considering the types of information that should be imparted to patients to engage them in their care, which are the most notable points identified by the analysis in your view? | [Free text] |
Intervention | Considering the indications for treatment that are advocated, what are the most notable findings identified by the analysis in your view? | [Free text] |
Considering the pharmacological treatments for specific patient groups identified by the analysis, what are the most notable findings in your view? | [Free text] | |
Considering the findings of the analysis related to falls prevention, what are the most notable in your view? | [Free text] | |
Integration | Considering how integration should occur between primary and secondary care, what are the most notable findings identified by the analysis in your view? | [Free text] |
Quality | Considering the findings of the 5IQ Comparative analysis related to quality metrics, what are the most notable findings in your view? | [Free text] |
Domain 2: How should the Framework be structured? | ||
How do you envisage the Framework being structured? Would you like to have it as a simple list of standards or have several levels of attainment (i.e. Level 1, Level 2, Level 3)? | [Free text] | |
Domain 3: What clinical standards are required? This domain seeks your opinions on what specific aspects of care merit having a clinical standard. We invite you to rate the importance or not of having particular standards and invite you to add any comments as free text. | ||
5IQ item | Question | Options |
Identification | How important is it to have a standard relating to identification of individuals with fragility fractures? |
Extremely important Very important Somewhat important Not so important Not at all important |
How important is it to have a standard relating to identification of individuals with common risk factors for osteoporosis (e.g. age 70 years or over, early menopause, excessive alcohol intake, family history, height loss, low body mass index/weight, prolonged immobility, smoking)? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to identification of individuals who take medicines associated with bone loss and/or increased fracture risk? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to identification of individuals with conditions associated with bone loss and/or increased fracture risk? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
Investigation | How important is it to have a standard relating to biochemical investigations of individuals undergoing assessment? |
Extremely important Very important Somewhat important Not so important Not at all important |
How important is it to have a standard relating to BMD testing of individuals undergoing assessment? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to use of risk assessment tools for individuals undergoing assessment? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to How important is it to have a standard relating to vertebral fracture assessment for individuals undergoing assessment? for individuals undergoing assessment? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to falls risk assessment for individuals undergoing assessment? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to scenarios when referral to a specialist is required? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
Information | How important is it to have a standard relating to what information should be imparted to patients to engage them in their care (e.g. information on calcium intake, sun exposure, the relationship between osteoporosis and fracture risk, exercise and other information)? |
Extremely important Very important Somewhat important Not so important Not at all important |
Intervention |
The 5IQ analysis identified a broad range of indications for treatment, as listed below. In your opinion, which of the following indications for treatment should feature in osteoporosis clinical guidelines? Please indicate in priority order (where number 1 is the highest priority). Only provide rankings for those indications which you believe should be included. [ ] Hip fracture [ ] Vertebral fracture [ ] Non-hip, non-vertebral fracture [ ] BMD T-Score ≤ –2.5 SD [ ] Osteopenia + FRAX® ≥3% Hip or ≥ 20% MOF [ ] Osteopenia + RFs or eligible by OSTA or SCORE [ ] Osteopenia + ≥10 years postmenopausal [ ] FRAX® or Garvan ≥3% Hip or ≥ 20% MOF [ ] Eligible by OSTA, MORES or SCORE [ ] QCT <80 mg/cm3 [ ] Height loss >4 cm [ ] Androgen deprivation therapy use [ ] Aromatase inhibitor use [ ] Glucocorticoid use [ ] Country-specific thresholds |
[Select items and rank according to priority] |
How important is it to have a standard relating to which pharmacological treatments should be recommended for specific patient groups? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to which non-pharmacological interventions should be recommended? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to description of side effects associated with pharmacological treatments? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to monitoring of treatment with pharmacologic agents? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to duration of treatment with pharmacologic agents? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to treatment adherence with pharmacologic agents? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
How important is it to have a standard relating to referral of patients to falls prevention programmes? |
Extremely important Very important Somewhat important Not so important Not at all important |
|
Integration | How important is it to have a standard relating to provision of a long-term management plan to the patients and/or primary care provider? |
Extremely important Very important Somewhat important Not so important Not at all important |
Quality | How important is it to have a standard relating to what quality metrics should be in place to assess adherence with guidelines-based care? |
Extremely important Very important Somewhat important Not so important Not at all important |
General | ||
Do you have any other comments related to the development of the Framework clinical standards? | [Free text] |